Global vaccine safety blueprint 2.0 (‎GVSB2.0)‎ 2021-2023 - ISS-G20 Laboratorium Repository

This Global Vaccines Safety Blueprint 2.0 (GVSB2.0) was developed through a step-wise consensus process to define the strategic priorities and objectives in the area of vaccines safety for 2021 to 2023 and beyond. The overall vision, goals and operating principles for a vaccine safety monitoring system described in the GVSB2.0 are equally relevant for medicines and for building product-agnostic pharmacovigilance systems in countries. Where possible, we need to build common systems and approaches that are smart, product-agnostic, address common needs and advance the principles of work-sharing and reliance to take into consideration competing priorities in resource-limited settings. For example, how we collect and manage data (databases) may not be very different between vaccines and medicines; on the other hand, the principles of benefit risk assessment and how risks are communicated requires specialized and perceptive handling for vaccines. 

Entire content available on: https://www.who.int/europe/publications/i/item/9789240036963